Iovance Biotherapeutics, Inc. (IOVA)
8.79
+0.09
(+1.03%)
USD |
NASDAQ |
Sep 04, 16:00
8.75
-0.04
(-0.46%)
After-Hours: 20:00
Iovance Biotherapeutics Cash and Short Term Investments (Annual) : 296.98M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 296.98M |
| December 31, 2024 | 323.78M |
| December 31, 2023 | 279.87M |
| December 31, 2022 | 471.84M |
| December 31, 2021 | 504.41M |
| December 31, 2020 | 629.44M |
| December 31, 2019 | 307.08M |
| December 31, 2018 | 468.52M |
| December 31, 2017 | 145.37M |
| Date | Value |
|---|---|
| December 31, 2016 | 166.47M |
| December 31, 2015 | 103.70M |
| December 31, 2014 | 44.91M |
| December 31, 2013 | 19.67M |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 0.5196M |
| December 31, 2010 | 1.298M |
| December 31, 2009 | 0.0084M |
| December 31, 2008 | 0.0031M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Amgen, Inc. | 9.129B |
| AVITA Medical, Inc. | 18.18M |
| Halozyme Therapeutics, Inc. | 142.82M |
| Neurocrine Biosciences, Inc. | 1.480B |
| Editas Medicine, Inc. | 146.64M |